Here are four points:
1. Under the research agreement, the two companies will create precision diagnostics for pathogens and their antimicrobial resistances in infectious diseases.
2. A biotech company, bioMérieux develops in vitro diagnostics for infectious diseases.
3. bioMérieux will team up with George Weinstock, PhD, who is a Jackson Laboratory professor, Evnin Family Chair and director of microbial genomics.
4. Dr. Weinstock’s laboratory is focused on next-generation DNA sequencing and metagenomic analysis.
More articles on quality & infection control:
FDA recommends all US blood donations should be screened for Zika — 5 highlights
Bringing caregivers into the fold: 5 strategies for nurses to improve the patient experience
Mylan to offer $300 generic to EpiPen auto-injector in effort to save face: 4 things to know
